Authors
Groot Koerkamp, M. L.Vasmel, J. E.
Russell, N. S.
Shaitelman, S. F.
Anandadas, Carmel N
Currey, A.
Vesprini, D.
Keller, B. M.
De-Colle, C.
Han, K.
Braunstein, L. Z.
Mahmood, F.
Lorenzen, E. L.
Philippens, M. E. P.
Verkooijen, H. M.
Lagendijk, J. J. W.
Houweling, A. C.
van den Bongard, H.
Kirby, A. M.
Affiliation
Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.Issue Date
2020
Metadata
Show full item recordAbstract
Current research in radiotherapy (RT) for breast cancer is evaluating neoadjuvant as opposed to adjuvant partial breast irradiation (PBI) with the aim of reducing the volume of breast tissue irradiated and therefore the risk of late treatment-related toxicity. The development of magnetic resonance (MR)-guided RT, including dedicated MR-guided RT systems [hybrid machines combining an MR scanner with a linear accelerator (MR-linac) or 60Co sources], could potentially reduce the irradiated volume even further by improving tumour visibility before and during each RT treatment. In this position paper, we discuss MR guidance in relation to each step of the breast RT planning and treatment pathway, focusing on the application of MR-guided RT to neoadjuvant PBI.Citation
Groot Koerkamp ML, Vasmel JE, Russell NS, Shaitelman SF, Anandadas CN, Currey A, et al. Optimizing MR-Guided Radiotherapy for Breast Cancer Patients. Frontiers in Oncology. 2020;10:1107.Journal
Frontiers in OncologyDOI
10.3389/fonc.2020.01107PubMed ID
32850318Additional Links
https://dx.doi.org/10.3389/fonc.2020.01107Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.3389/fonc.2020.01107
Scopus Count
Collections
Related articles
- Magnetic resonance imaging-guided single-fraction preoperative radiotherapy for early-stage breast cancer (the RICE trial): feasibility study.
- Authors: Qadir A, Singh N, Dean J, Brown K, Tacey M, Mann B, Kron T, Cahoon G, Lau E, Scott AM, Yeo B, Loh SW, Uribe S, Moe AAK, Ireland-Jenkins K, McAuley R, McDermont L, Ooi WM, Ng S, Chao M, Foroudi F
- Issue date: 2024 Nov 7
- Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial-a study protocol.
- Authors: Civil YA, Oei AL, Duvivier KM, Bijker N, Meijnen P, Donkers L, Verheijen S, van Kesteren Z, Palacios MA, Schijf LJ, Barbé E, Konings IRHM, -van der Houven van Oordt CWM, Westhoff PG, Meijer HJM, Diepenhorst GMP, Thijssen V, Mouliere F, Slotman BJ, van der Velde S, van den Bongard HJGD
- Issue date: 2023 May 9
- MR-guidance--a clinical study to evaluate a shuttle- based MR-linac connection to provide MR-guided radiotherapy.
- Authors: Bostel T, Nicolay NH, Grossmann JG, Mohr A, Delorme S, Echner G, Häring P, Debus J, Sterzing F
- Issue date: 2014 Jan 9
- IPEM topical report: guidance on the use of MRI for external beam radiotherapy treatment planning().
- Authors: Speight R, Dubec M, Eccles CL, George B, Henry A, Herbert T, Johnstone RI, Liney GP, McCallum H, Schmidt MA
- Issue date: 2021 Feb 25
- Partial breast irradiation with the 1.5 T MR-Linac: First patient treatment and analysis of electron return and stream effects.
- Authors: Nachbar M, Mönnich D, Boeke S, Gani C, Weidner N, Heinrich V, Lo Russo M, Livi L, Winter J, Tsitsekidis S, Dohm O, Thorwarth D, Zips D, De-Colle C
- Issue date: 2020 Apr